[Treatment of cryptococcosis in patients with acquired immunodeficiency syndrome].
Graybill
J R
JR
University of Texas, Department of Medicine, Division of Infectious Diseases, San Antonio, USA.
D017088:AIDS-Related Opportunistic Infections / Q000175:diagnosis / Q000188:drug therapy / Q000628:therapy*; D000328:Adult; D000666:Amphotericin B / Q000627:therapeutic use; D000818:Animals; D000935:Antifungal Agents / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003453:Cryptococcosis / Q000175:diagnosis / Q000188:drug therapy / Q000628:therapy*; D015725:Fluconazole / Q000627:therapeutic use; D005437:Flucytosine / Q000627:therapeutic use; D006801:Humans; D007167:Immunotherapy; D017964:Itraconazole / Q000627:therapeutic use; D016919:Meningitis, Cryptococcal / Q000175:diagnosis / Q000188:drug therapy / Q000628:therapy; D051379:Mice; D015337:Multicenter Studies as Topic; D014611:Vaccination
D000935:Antifungal Agents; D017964:Itraconazole; D000666:Amphotericin B; D015725:Fluconazole; D005437:Flucytosine